| Name |
Lasix 40 mg tablete |
| Marketing Authorisation Number |
HR-H-797987648 |
| Active Substance |
furosemid |
| Composition |
jedna tableta sadrži 40 mg furosemida |
| Pharmaceutical Form |
tableta |
| Manufacturer |
Opella Healthcare International SAS, Compiegne, Francuska |
| Marketing Authorisation Holder |
Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska |
| Marketing Authorisation Date |
01.09.2023 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/537 |
| Registration Number |
381-12-01/70-23-25 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C03CA01 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
